🇺🇸 FDA
Pipeline program

PVS-10200

PVS 03-001

Phase 2 mab completed

Quick answer

PVS-10200 for Peripheral Artery Disease is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Peripheral Artery Disease
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials